These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 3742494)
1. Phase II clinical trial of diaziquone in the treatment of patients with recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study. Slayton RE; Blessing JA; Stehman FB; Malfetano J Cancer Treat Rep; 1986 Sep; 70(9):1127-8. PubMed ID: 3742494 [No Abstract] [Full Text] [Related]
2. Phase II evaluation of diaziquone in recurrent head and neck cancer. Kish JA; Ensley J; Al-Sarraf M Cancer Treat Rep; 1986 May; 70(5):671-2. PubMed ID: 3708616 [No Abstract] [Full Text] [Related]
3. Phase II clinical trial of diaziquone in the treatment of patients with epithelial ovarian cancer: a Gynecologic Oncology Group Study. Slayton RE; Blessing JA; Sutton GP; Homesley HD; Park R Cancer Treat Rep; 1986 Feb; 70(2):309-10. PubMed ID: 3948196 [No Abstract] [Full Text] [Related]
4. Phase II trial of diaziquone in advanced large bowel carcinoma in previously treated and untreated patients: a Southwest Oncology Group Study. Shildt R; Stephens RL; Subramanian VP; Baker LH; Fletcher WS; O'Bryan RM; McCracken JD Cancer Treat Rep; 1985 Jun; 69(6):709-10. PubMed ID: 4016775 [No Abstract] [Full Text] [Related]
5. Phase II trial of diaziquone in advanced upper aerodigestive cancer. Creagan ET; Long HJ; Kvols LK; Edmonson JH; O'Fallon JR Cancer Treat Rep; 1985 Jan; 69(1):141. PubMed ID: 3967258 [No Abstract] [Full Text] [Related]
6. Phase II trial of AMSA in patients with advanced or recurrent squamous cell carcinoma of the cervix: a gynecologic oncology group study. Bonomi P; Blessing JA; Sedlacek TV; Homesley HD; DiSaia PJ Cancer Treat Rep; 1983 Feb; 67(2):197-8. PubMed ID: 6687445 [No Abstract] [Full Text] [Related]
7. Phase II trial of etoposide in the management of advanced or recurrent non-squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Slayton RE; Blessing JA; Homesley HD Cancer Treat Rep; 1984 Dec; 68(12):1513-4. PubMed ID: 6509456 [No Abstract] [Full Text] [Related]
8. Phase II evaluation of diaziquone in pancreatic carcinoma: a Southwest Oncology Group Study. Tilchen EJ; Fleming T; Mills G; Oishi N; Bonnett JD; Natale RB; Harker G; Coltman CA Cancer Treat Rep; 1987 Dec; 71(12):1309-10. PubMed ID: 3690548 [No Abstract] [Full Text] [Related]
9. Teniposide in squamous cell carcinoma of the cervix: a phase II trial of the Gynecologic Oncology Group. Muss HB; Bundy BN; Yazigi R; Yordan E Cancer Treat Rep; 1987 Sep; 71(9):873-4. PubMed ID: 3621222 [No Abstract] [Full Text] [Related]
10. Phase II trial of diaziquone in patients with refractory and relapsing multiple myeloma: a Southwest Oncology Group Study. Stuckey WJ; Crowley J; Baker LH; Larrimer NR; Hanson KH; Bonnet JD; White LA Cancer Treat Rep; 1987 Nov; 71(11):1095-6. PubMed ID: 3119202 [No Abstract] [Full Text] [Related]
11. Phase II study of aclarubicin and diaziquone in the treatment of advanced small cell bronchogenic carcinoma (EST 4581): an Eastern Cooperative Oncology Group Study. Abeloff MD; Finkelstein DM; Chang AY; Camacho FJ; Creech RH; Ettinger DS Cancer Treat Rep; 1985 Apr; 69(4):451-2. PubMed ID: 3857972 [No Abstract] [Full Text] [Related]
12. A phase II clinical trial of diaziquone (AZQ) in the treatment of patients with recurrent adenocarcinoma and adenosquamous carcinoma of the cervix. A Gynecologic Oncology Group study. Slayton RE; Blessing JA; Rettenmaier M; Ball H Invest New Drugs; 1989 Nov; 7(4):337-40. PubMed ID: 2599803 [TBL] [Abstract][Full Text] [Related]
13. Phase II evaluation of altretamine for advanced or recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study. Rose PG; Blessing JA; Arseneau J Gynecol Oncol; 1996 Jul; 62(1):100-2. PubMed ID: 8690279 [TBL] [Abstract][Full Text] [Related]
14. Cisplatin and pentoxifylline in advanced or recurrent squamous cell carcinoma of the cervix: a phase II trial of the Gynecologic Oncology Group. Mannel RS; Blessing JA; Boike G Gynecol Oncol; 2000 Oct; 79(1):64-6. PubMed ID: 11006033 [TBL] [Abstract][Full Text] [Related]
15. Phase II trial of diaziquone in advanced ovarian carcinoma. European Organization for Research on Treatment of Cancer Early Clinical Trials Group. Lund B; Bramwell V; Renard J; Hansen HH; Dombernowsky P Cancer Treat Rep; 1985 Mar; 69(3):339-40. PubMed ID: 3872170 [No Abstract] [Full Text] [Related]
16. Phase II trial of the combination of bryostatin-1 and cisplatin in advanced or recurrent carcinoma of the cervix: a New York Gynecologic Oncology Group study. Nezhat F; Wadler S; Muggia F; Mandeli J; Goldberg G; Rahaman J; Runowicz C; Murgo AJ; Gardner GJ Gynecol Oncol; 2004 Apr; 93(1):144-8. PubMed ID: 15047228 [TBL] [Abstract][Full Text] [Related]
17. Phase II trial of menogaril in patients with squamous carcinoma of the cervix: a Gynecologic Oncology Group study. Sutton GP; Blessing JA; Barrett RJ; Gallup DG Gynecol Oncol; 1994 Feb; 52(2):229-31. PubMed ID: 8314144 [TBL] [Abstract][Full Text] [Related]
18. Phase II clinical trial of diaziquone in bronchogenic carcinoma. Chiuten DF; Umsawasdi T; Dhingra HM; Murphy WK; Spitzer G; Carr DT; Bodey GP; Valdivieso M Cancer Treat Rep; 1985; 69(7-8):921-2. PubMed ID: 4016800 [No Abstract] [Full Text] [Related]
19. Prolonged oral etoposide in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study. Rose PG; Blessing JA; Van Le L; Waggoner S Gynecol Oncol; 1998 Aug; 70(2):263-6. PubMed ID: 9740702 [TBL] [Abstract][Full Text] [Related]
20. Mitoxantrone and advanced squamous cell carcinoma of the cervix: a Southwest Oncology Group Study. Hilgers RD; Von Hoff DD; Stephens RL; Boutselis JG Cancer Treat Rep; 1986 Apr; 70(4):527-8. PubMed ID: 3698047 [No Abstract] [Full Text] [Related] [Next] [New Search]